IGF1 and prostate carcinoma: Gut bacteria can regulate insulin-like growth factor-1 (IGF1) levels in the host via short-chain fatty acids, thereby promoting the proliferation of prostate cancer cells, then modulating the gut microbiota to influence the gut microbiota-IGF1-prostate axis may be beneficial in the prevention and treatment of prostate cancer (104).